Low T3 syndrome is associated with poor prognosis in patients with hepatitis B virus-related acute-on-chronic liver failure

References

• Lee S, Farwell AP. Euthyroid sick syndrome.Compr Physiol. 2016;6(2):1071–1080.
   PubMed Web of Science ®Google Scholar
• Maiden MJ, Torpy DJ. Thyroid hormones in critical illness. Crit Care Clin. 2019;35(2):375–388.
   PubMed Web of Science ®Google Scholar
• Liu J, Wu X, Lu F, et al. Low T3 syndrome is a strong predictor of poor outcomes in patients with community-acquired pneumonia. Sci Rep. 2016;6:22271.
   PubMed Web of Science ®Google Scholar
• Gao R, Chen RZ, Xia Y, et al. Low T3 syndrome as a predictor of poor prognosis in chronic lymphocytic leukemia. Int J Cancer. 2018;143(3):466–477.
   PubMed Web of Science ®Google Scholar
• Gao R, Liang JH, Wang L, et al. Low T3 syndrome is a strong prognostic predictor in diffuse large B cell lymphoma. Br J Haematol. 2017;177(1):95–105.
   PubMed Web of Science ®Google Scholar
• Zhao X, Zhang R, Jiang H, et al. Combined use of low T3 syndrome and NT-proBNP as predictors for death in patients with acute decompensated heart failure. BMC Endocr Disord. 2021;21(1):140.
   PubMed Web of Science ®Google Scholar
• Abdu FA, Mohammed AQ, Liu L, et al. Low free triiodothyronine as a predictor of poor prognosis in patients with myocardial infarction with non-obstructive coronary arteries. Front Endocrinol (Lausanne). 2021;12:681978.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang W, Zhang K, et al. Association between low T3 syndrome and poor prognosis in adult patients with acute myocarditis. Front Endocrinol (Lausanne). 2021;12:571765.
   PubMed Web of Science ®Google Scholar
• Yin GL, Huang JY, Tian T, et al. Low T3 syndrome is a prognostic marker of poor outcomes in secondary hemophagocytic lymphohistiocytosis. Leuk Lymphoma. 2020;61(12):2947–2954.
   PubMed Web of Science ®Google Scholar
• Huang GQ, Zeng YY, Cheng QQ, et al. Low triiodothyronine syndrome is associated with hemorrhagic transformation in patients with acute ischaemic stroke. Aging (Albany NY). 2019;11(16):6385–6397.
   PubMedGoogle Scholar
• Cornu MG, Martinuzzi A, Roel P, et al. Incidence of low-triiodothyronine syndrome in patients with septic shock. Rev Bras Ter Intensiva. 2020;32(4):514–520.
   PubMedGoogle Scholar
• Schultheiss UT, Steinbrenner I, Nauck M, et al. Thyroid function, renal events and mortality in chronic kidney disease patients: the German Chronic Kidney Disease study. Clin Kidney J. 2021;14(3):959–968.
   PubMed Web of Science ®Google Scholar
• Xu J, Wang L. Low T3 syndrome as a predictor of poor prognosis in patients with pyogenic liver abscess. Front Endocrinol (Lausanne). 2019;10:541.
   PubMed Web of Science ®Google Scholar
• Rink C, Siersleben U, Haerting J, et al. Development of the low-T3-syndrome and prognosis assessment in patients with liver cirrhosis. Gastroenterol J. 1991;51(3–4):138–141.
   PubMedGoogle Scholar
• Schweitzer A, Horn J, Mikolajczyk RT, et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546–1555.
   PubMed Web of Science ®Google Scholar
• Philips CA, Ahamed R, Abduljaleel JK, et al. Critical updates on chronic hepatitis B virus infection in 2021. Cureus. 2021;13(10):e19152.
   PubMed Web of Science ®Google Scholar
• Sarin SK, Choudhury A, Sharma MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13(4):353–390.
   PubMed Web of Science ®Google Scholar
• Zhao RH, Shi Y, Zhao H, et al. Acute-on-chronic liver failure in chronic hepatitis B: an update. Expert Rev Gastroenterol Hepatol. 2018;12(4):341–350.
   PubMed Web of Science ®Google Scholar
• Wu T, Li J, Shao L, et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure. Gut. 2018;67(12):2181–2191.
   PubMed Web of Science ®Google Scholar
• Boelen A, Kwakkel J, Fliers E. Beyond low plasma T3: local thyroid hormone metabolism during inflammation and infection. Endocr Rev. 2011;32(5):670–693.
   PubMed Web of Science ®Google Scholar
• Tang L, Covert E, Wilson E, et al. Chronic hepatitis B infection: a review. JAMA. 2018;319(17):1802–1813.
   PubMed Web of Science ®Google Scholar
• Shah S, Goldberg DS. Acute-on-chronic liver failure: update on pathogenesis, therapeutic targets, predictive models, and liver transplantation. Curr Opin Gastroenterol. 2021;37(3):173–178.
   PubMed Web of Science ®Google Scholar
• Biegelmeyer E, Scanagata I, Alves L, et al. T3 as predictor of mortality in any cause non-critically ill patients. Endocr Connect. 2021;10(8):852–860.
   PubMed Web of Science ®Google Scholar
• Li TP, Guan SH, Wang Q, et al. Soluble mannose receptor as a predictor of prognosis of hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol. 2019;25(37):5667–5675.
   PubMed Web of Science ®Google Scholar
• Li Q, Wang J, Lu M, et al. Acute-on-chronic liver failure from chronic-hepatitis-B, who is the behind scenes. Front Microbiol. 2020;11:583423.
   PubMed Web of Science ®Google Scholar
• Moreau R. The pathogenesis of ACLF: the inflammatory response and immune function. Semin Liver Dis. 2016;36(2):133–140.
   PubMed Web of Science ®Google Scholar
• Fliers E, Bianco AC, Langouche L, et al. Thyroid function in critically ill patients. Lancet Diabetes Endocrinol. 2015;3(10):816–825.
   PubMed Web of Science ®Google Scholar
• Hermus RM, Sweep CG, van der Meer MJ, et al. Continuous infusion of interleukin-1 beta induces a nonthyroidal illness syndrome in the rat. Endocrinology. 1992;131(5):2139–2146.
   PubMed Web of Science ®Google Scholar
• Bartalena L, Bogazzi F, Brogioni S, et al. Role of cytokines in the pathogenesis of the euthyroid sick syndrome. Eur J Endocrinol. 1998;138(6):603–614.
   PubMed Web of Science ®Google Scholar
• De Groot LJ. Non-thyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies. Crit Care Clin. 2006;22(1):57–86, vi.
   PubMed Web of Science ®Google Scholar
• Chang Y, Liu QY, Zhang Q, et al. Role of nutritional status and nutritional support in outcome of hepatitis B virus-associated acute-on-chronic liver failure. World J Gastroenterol. 2020;26(29):4288–4301.
   PubMed Web of Science ®Google Scholar
• de Vries EM, van Beeren HC, Ackermans MT, et al. Differential effects of fasting vs food restriction on liver thyroid hormone metabolism in male rats. J Endocrinol. 2015;224(1):25–35.
   PubMed Web of Science ®Google Scholar
• Tajiri K, Shimizu Y. Liver physiology and liver diseases in the elderly. World J Gastroenterol. 2013;19(46):8459–8467.
   PubMed Web of Science ®Google Scholar
• Wu W, Yan H, Zhao H, et al. Characteristics of systemic inflammation in hepatitis B-precipitated ACLF: differentiate it from No-ACLF. Liver Int. 2018;38(2):248–257.
   PubMed Web of Science ®Google Scholar
• Elbers L, Squizzato A, Gerdes V. Thyroid disorders and hemostasis. Semin Thromb Hemost. 2018;44(7):676–682.
   PubMed Web of Science ®Google Scholar
• Li L, Guo CY, Yang J, et al. Negative association between free triiodothyronine level and international normalized ratio in euthyroid subjects with acute myocardial infarction. Acta Pharmacol Sin. 2011;32(11):1351–1356.
   PubMed Web of Science ®Google Scholar
• Gullu S, Sav H, Kamel N. Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism. Eur J Endocrinol. 2005;152(3):355–361.
   PubMed Web of Science ®Google Scholar
• Zhang X, Chen P, Gao H, et al. Bacterial infection and predictors of mortality in patients with autoimmune liver disease-associated acute-on-chronic liver failure. Can J Gastroenterol Hepatol. 2018;2018:5108781.
   PubMed Web of Science ®Google Scholar
• Mani I, Alexopoulou A, Vasilieva L, et al. Human beta-defensin-1 is a highly predictive marker of mortality in patients with acute-on-chronic liver failure. Liver Int. 2019;39(2):299–306.
   PubMed Web of Science ®Google Scholar
• Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31(4):864–871.
   PubMed Web of Science ®Google Scholar
• Jalan R, Saliba F, Pavesi M, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 2014;61(5):1038–1047.
   PubMed Web of Science ®Google Scholar
• Pingitore A, Galli E, Barison A, et al. Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. J Clin Endocrinol Metab. 2008;93(4):1351–1358.
   PubMed Web of Science ®Google Scholar
• Lisco G, De Tullio A, Iacoviello M, et al. Congestive heart failure and thyroid dysfunction: the role of the low T3 syndrome and therapeutic aspects. Endocr Metab Immune Disord Drug Targets. 2020;20(5):646–653.
   PubMed Web of Science ®Google Scholar